The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•26 June 2026•

1 min read

B.Riley initiates Nutex Health coverage with Buy rating, $290 target

Key Facts

1B.Riley initiated coverage on Nutex Health Inc. with a Buy rating and a $290 price target.

Reflecting confidence in alternative healthcare models, B.Riley initiated coverage on Nutex Health Inc. with a Buy rating and a price target of $290. According to the report, the rating is based on a positive assessment of the company's strategy in the micro-hospital space.

The analyst sees Nutex's micro-hospital model filling a clear gap in healthcare, particularly in underserved areas. The report highlights strong liquidity and a new sale-leaseback model supporting expansion, with expectations of 3 to 5 new hospital openings annually.

NUTX shares closed at $149.10 on June 25, 2026, well below the $290 target, leaving significant upside. Investors may watch for updates on expansion plans and upcoming quarterly results as potential catalysts.

Sources: